ChronoScale extends $2M loan maturity to Nov 12, 2026; permits Ekso Bionics sale

EKSO BIONICS HOLDINGS, INC.

Term loan of $2.0M outstanding extended to Nov 12, 2026 from Sept 12, 2026 via amendment with B. Riley Commercial Capital.
Amendment allows sale of Guarantor Ekso Bionics, Inc. as Permitted Disposition, auto-releasing Lender's liens on sold assets/capital stock.
Waiver dated Apr 23, 2026: Proposed Financing does not accelerate maturity but qualifies as Qualified Financing for conversion right.
Loan Parties confirm $2M principal outstanding and no defenses; all other Note terms unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.